ALLMedicine™ Robotic Surgery Center
Research & Reviews 285 results
https://doi.org/10.1016/j.prro.2022.12.005
Practical Radiation Oncology; Berlin E, Ma DJ et. al.
Jan 5th, 2023 - The purpose of this paper is to summarize the literature and practical recommendations from experienced centers for close margins following transoral robotic surgery (TORS) for HPV-positive oropharyngeal carcinoma.
https://doi.org/10.1016/j.anl.2022.12.006
Auris, Nasus, Larynx; Cho KJ, Park JO et. al.
Dec 27th, 2022 - Soft tissue necrosis (STN) can occur after transoral robotic surgery (TORS) with radiation therapy (RT). We investigated the usefulness of local flap reconstruction for preventing STN after TORS in patients with tonsillar cancer. This case-control...
https://doi.org/10.1002/hed.27271
Head & Neck; Lee YK, Manek R et. al.
Dec 23rd, 2022 - Excessive flexion of the neck and upper back from severe kyphosis of the thoracic spine may limit treatment options for head and neck cancer (HNC). We describe an innovative approach to transoral robotic surgery (TORS) in a patient with severe tho...
https://doi.org/10.1002/hed.27282
Head & Neck; Janopaul-Naylor JR, Rupji M et. al.
Dec 23rd, 2022 - Postoperative mortality for oropharynx squamous cell carcinoma (OPSCC) with transoral robotic surgery (TORS) varies from 0.2% to 6.5% on trials; the real-world rate is unknown. NCDB study from 2010 to 2017 for patients with cT1-2N0-2M0 OPSCC with ...
https://doi.org/10.1002/hed.27283
Head & Neck; Costantino A, Sampieri C et. al.
Dec 22nd, 2022 - To develop machine learning (ML) models for predicting positive margins in patients undergoing transoral robotic surgery (TORS). Data from 453 patients with laryngeal, hypopharyngeal, and oropharyngeal squamous cell carcinoma were retrospectively ...
News 7 results
https://www.medscape.com/viewarticle/961779
Oct 29th, 2021 - NEW YORK (Reuters Health) - Among carefully selected patients with HPV-positive oropharynx squamous cell carcinoma (OPSCC) undergoing primary transoral robotic surgery (TORS), it is likely that 25% will need radiochemotherapy afterward, a single-c...
https://www.staging.medscape.com/viewarticle/940648
Nov 10th, 2020 - NEW YORK (Reuters Health) - In selected older patients with human papillomavirus-associated oropharyngeal cancer, transoral robotic surgery (TORS) can boost survival and avert the need for chemotherapy, researchers found in a single-center study. ...
https://www.medscape.com/viewarticle/940648
Nov 10th, 2020 - NEW YORK (Reuters Health) - In selected older patients with human papillomavirus-associated oropharyngeal cancer, transoral robotic surgery (TORS) can boost survival and avert the need for chemotherapy, researchers found in a single-center study. ...
https://www.medscape.com/viewarticle/936219
Aug 24th, 2020 - Transoral robotic surgery (TORS) was associated with better survival and improved surgical outcomes in comparison with nonrobotic surgery in patients with early-stage oropharyngeal cancer in a retrospective analysis of nearly 10,000 cases. The sur...
https://www.medscape.com/viewarticle/914286
Jun 12th, 2019 - CHICAGO — For patients with oropharyngeal squamous cell cancer (OPSCC), opting for radiation therapy rather than surgery may result in better swallowing outcomes, which in turn may mean a better quality of life, according to new findings. The find...